SNGX Chart
- 52-Week Range: $0.40 - $1.31
- Market Capitalization: $22.43M
- Short Percentage: 0%
- Target Price: $4.88
- Shares Outstanding: 42.95M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
SNGX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Soligenix Receives US Patent Allowance for its Thermostabilized Vaccine PlatformPRNewsWire | May 23rd
- Soligenix Corporate Update Letter - Key Highlights and Upcoming CatalystsPRNewsWire | January 10th
- Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal StudiesPRNewsWire | January 4th
- Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus VaccinePRNewsWire | December 2nd
- Soligenix Announces Recent Accomplishments And Third Quarter 2021 Financial ResultsPRNewsWire | November 12th
Company Info
Website: https://www.soligenix.com
Address: 29 Emmons Drive, Princeton, NJ, United States, 08540
Sector: Healthcare
Industry: Biotechnology
Full time employees: 13
Address: 29 Emmons Drive, Princeton, NJ, United States, 08540
Sector: Healthcare
Industry: Biotechnology
Full time employees: 13
$SNGX out of the way
$SNGX can’t wait to get in this tomorrow lfg
$SNGX There is nothing wrong with a decent pullback
$SNGX I actually want the market pullback 5% is pretty crazy how this market keep going and going
$SNGX bear trap dude
$SNGX must buyyy
$SNGX Holding Pattern
$SNGX not yet time to short
$SNGX just added more
$SNGX time will come